SERPINB5 and breast carcinoma: For example, dCas9-VP64, dCas9-VPR, and dCas9-p300 were employed to activate the expression of MASPIN and REPRIMO in a number of cell lines, including H157 lung cancer and MCF7 breast cancer cells.